What outpatient workup and management plan is appropriate for a 50‑year‑old woman with obstructive sleep apnea, hypertension, prior transient ischemic attack, hyperlipidemia, metabolic‑associated steatohepatitis, and diabetes mellitus who presents with six‑month history of weight gain, non‑pitting edema, shortness of breath and dyspnea on exertion, with a normal echocardiogram, normal BNP, and no pulmonary hypertension?

Outpatient Workup and Management Plan

This patient's presentation of non-pitting edema, weight gain, and dyspnea with normal cardiac workup most likely represents a non-cardiac etiology—specifically, undertreated OSA with metabolic complications, obesity-related edema, or lymphedema—and requires systematic evaluation of OSA treatment adherence, metabolic screening, and exclusion of alternative causes of edema.

Immediate Assessment Priorities

1. OSA Treatment Evaluation

• Verify CPAP adherence and efficacy 1, 2
  • Download CPAP data to assess hours of use, residual apnea-hypopnea index (AHI), and mask leak
  • Target ≥4 hours/night on 70% of nights for adequate adherence
  • If non-adherent or residual symptoms persist, consider mandibular advancement device as alternative 1
  • Weight loss is critical: comprehensive lifestyle intervention with reduced-calorie diet, ≥150 minutes/week physical activity, and behavioral counseling 2, 3

2. Differentiate Edema Type

First, exclude lymphedema 4:

• Perform Stemmer sign: attempt to lift skin fold at base of second toe
  • Positive (thickened, unable to lift) = lymphedema → refer for lymphoscintigraphy
  • Negative with high suspicion → still refer for lymphoscintigraphy
  • Note: obesity can cause false-positive

If not lymphedema, determine mechanism 4:

• Increased hydrostatic pressure: cardiac (already excluded), renal failure, cirrhosis
• Decreased oncotic pressure: nephrotic syndrome, liver failure, malnutrition

3. Comprehensive Metabolic Workup

Laboratory evaluation 5, 6:

• Renal function: BUN, creatinine, eGFR
• Urinalysis with protein-to-creatinine ratio (exclude nephrotic syndrome)
• Liver function tests: AST, ALT, albumin, bilirubin (assess MASH severity)
• Fasting lipid panel: total cholesterol, LDL, HDL, triglycerides
• Hemoglobin A1c (diabetes control)
• Thyroid function: TSH, free T4 (6% prevalence of thyroid dysfunction in OSA) 5
• Uric acid (29% prevalence of hyperuricemia in OSA) 5

Imaging studies 5:

• Abdominal ultrasound: assess for cirrhosis, portal hypertension, hepatic steatosis severity
• Consider Fibrosis-4 Index calculation for MASH staging 3

Cardiovascular assessment 5, 7:

• 24-hour ambulatory blood pressure monitoring (OSA causes nocturnal hypertension and abnormal BP variability)
• ECG: screen for arrhythmias (16% prevalence in OSA patients) 5
• Repeat echocardiogram if initial study did not specifically assess:
  • Diastolic function parameters (E/e' ratio)
  • Left ventricular wall thickness
  • Consider cardiac amyloidosis if unexplained LV thickening 4

Pulmonary evaluation 5:

• Spirometry: exclude COPD (8% prevalence) or asthma (12% prevalence) in OSA
• Arterial blood gas if obesity hypoventilation suspected (BMI >30 with daytime hypercapnia)

Additional screening 3, 5:

• GERD symptoms: 17% prevalence in OSA
• Depression/anxiety screening: PHQ-9, GAD-7 (17% prevalence)
• Sleep quality questionnaire: Epworth Sleepiness Scale

Management Algorithm

Step 1: Optimize OSA Treatment

• If CPAP non-adherent: troubleshoot mask fit, pressure settings, consider auto-CPAP or alternative device 1
• Intensive weight loss intervention (strongest recommendation) 2:
  • Structured program: 1200-1500 kcal/day diet + ≥230 minutes/week moderate activity + behavioral counseling
  • Consider weight-loss medications if BMI ≥27 with complications 8, 3
  • Consider bariatric surgery referral if BMI ≥35 8

Step 2: Address Identified Comorbidities

Based on workup results:

• Nephrotic syndrome: nephrology referral
• Cirrhosis/portal hypertension: hepatology referral, diuretic therapy
• Uncontrolled hypertension: optimize antihypertensives
  • Consider beta-blockers or ACE inhibitors/ARBs for OSA-related hypertension 7
  • SGLT2 inhibitors beneficial for diabetes + obesity + nocturnal hypertension 7
• Thyroid dysfunction: initiate or adjust thyroid replacement
• Worsening MASH: hepatology referral, consider GLP-1 agonist 7

Step 3: Symptomatic Edema Management

Only after excluding serious causes 4:

• Compression stockings for venous insufficiency
• Leg elevation
• Sodium restriction (<2000 mg/day) 9
• Diuretics only if specific indication identified (avoid empiric use)

Common Pitfalls to Avoid

1. Do not assume cardiac etiology despite multiple risk factors when BNP and echo are normal 4
2. Do not overlook obesity as primary cause of both OSA and edema 4
3. Do not miss nephrotic syndrome—always check urinalysis with proteinuria quantification 4
4. Do not forget that normal BNP can occur in HFpEF with obesity (higher BMI lowers natriuretic peptide levels) 4
5. Do not neglect systematic comorbidity screening—40% of OSA patients require medication changes after structured workup 5
6. Do not prescribe pharmacologic therapy for OSA (insufficient evidence) 1

Follow-Up Plan

• 2-4 weeks: review laboratory results, initiate identified treatments
• 3 months: reassess symptoms, weight, CPAP adherence, BP control
• 6 months: repeat metabolic labs, consider repeat echo if diastolic dysfunction suspected
• Specialist referrals as indicated: nephrology, hepatology, cardiology (if new findings), sleep medicine (if OSA refractory), obesity medicine 4

The structured workup will likely identify 2+ new actionable diagnoses given this patient's risk profile 5, with treatment modifications expected in multiple domains including pharmacotherapy (40%), specialist referral (54%), and lifestyle interventions (85%).